Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Inga Jona Ingimarsdottir"'
Publikováno v:
ESC Heart Failure, Vol 11, Iss 6, Pp 4081-4091 (2024)
Abstract Introduction The incidence of heart failure (HF) is increasing, largely because populations are both ageing and growing. Most clinical HF treatment trials are conducted on selected cohorts, only a few of which include elderly patients, among
Externí odkaz:
https://doaj.org/article/3e86c037f8b848c3a2e672e4729d9b4f
Autor:
Andrea Ballatore, Michela Casella, Francisco Moscoso Costa, Marzia Giaccardi, Moti Haim, Inga Jóna Ingimarsdóttir, Nathan Mewton, Clara Van Ofwegen-Hanekamp, Pierre Ollitrault, Agnieszka Pawlak, Arian Sultan, Mariya Tokmakova, Christos Varounis, Vanessa Weberndörfer, Filip Zemrak, Matteo Anselmino
Publikováno v:
Journal of Interventional Cardiology, Vol 2024 (2024)
Background. Cardiologists are today exposed to a growing dose of ionising radiation in their practice. Radiation awareness and correct management of X-ray use are the cornerstone to comply with the principles of exposure optimization and justificatio
Externí odkaz:
https://doaj.org/article/4fe080305e584966a24dc872ed8a4f99
Autor:
Inga Jona, Ingimarsdottir
Publikováno v:
Laeknabladid. 108(11)
Autor:
Ea Rusch, Eirikur Jonsson, Klaus Brasso, Jan Adolfsson, Inga Jona Ingimarsdottir, Laufey Tryggvadottir, Hans H. Storm, Erik Holmberg, Anna Bill-Axelson, Gerda Engholm
Publikováno v:
European Journal of Cancer. 49:1984-1992
Introduction Register-based studies have shown large survival differences among prostate cancer patients in the Nordic countries. The aim of this study was to determine the background of such differences in Denmark, Iceland and Sweden. Material and m
Autor:
Inga Jona Ingimarsdottir, Klaus Brasso, Kasper Drimer Berg, Anne Mette Tranberg Kejs, Frederik Birkebæk Thomsen, Marta K. Mikkelsen, Rikke B. Hansen
Publikováno v:
European journal of cancer (Oxford, England : 1990). 72
During recent years, several new life-prolonging therapeutic options have been introduced for patients with metastatic prostate cancer (mPCa). The aim of the present study was to evaluate the changes in the survival of patients diagnosed with mPCa pr
Publikováno v:
Acta oncologica (Stockholm, Sweden). 55(1)
Background. The Danish Cancer Registry (DCR) is the oldest nationwide population-based cancer registry in the Nordic countries. At the time of the study the DCR recorded date of diagnosis, tumor stage and initial treatment. The validity of the clinic
Publikováno v:
Laeknabladid. 98(5)
Publikováno v:
Ugeskrift for laeger. 169(2)
Previous studies in Denmark have reported an increase in prostate cancer (PC) incidence- and mortality rates. So far, it has not been possible to establish the rising incidence as a consequence of an increase in diagnostic procedures. This study revi
Autor:
Inga Jona Ingimarsdottir
Publikováno v:
Journal of Clinical Oncology. 30:159-159
159 Background: Register-based studies have demonstrated large differences in relative survival and excess mortality following the diagnosis of PC in the Nordic countries. These differences may reflect differences in patient characteristics, diagnost